N'ime ụdị shuga 1, onye ọrịa nwere ike iji insulin rụọ ọrụ ngwa ngwa (mkpụmkpụ), mkpụmkpụ, ọkara, ogologo oge na nke agwakọtara.
Kedu onye ga - edepụta maka usoro ọgwụgwọ kachasị mma dabere na njirimara nke anụ ahụ. Ọ bụrụ na achọrọ insulin dị mkpirikpi, a na-eji Glulisin.
Na nkenke banyere insulin Glulizin
![](http://img.diabetesentity.com/img/diab-2020/8504/ultrakorotkij-insulin-glulizin-harakteristiki-i-osobennosti-primeneniya.gif)
Molecule insulin
Insulin Glulisine bụ nnwale nke insulin mmadụ, nke ya na ụkpụrụ ahụ na homonụ a. Mana site na okike, ọ na - eme ngwa ngwa ma nwee mmetụta dị mkpụmkpụ.
A gosipụtara Glulisin dị ka ihe ngwọta maka nchịkwa subcutaneous. Ọ dị ka mmiri mmiri na-enweghị mmerụ emerụ.
Aha ahia maka ogwu na nnonye ya: Apidra, Epidera, Apidra Solostar. Ebumnuche bụ isi nke ọgwụ bụ ịhazi metabolism.
Dabere na ahụmịhe bara uru, a ga-amata uru na ọghọm ndị a:
- na-eme ngwa ngwa karịa homonụ mmadụ (+);
- na-emeju afọ ojuju nri insulin (+);
- enweghị ike ịkọwapụta mmetụta ọgwụ dị na ọkwa glucose (-);
- ike dị elu - otu na - ewelata shuga karịa insulins ndị ọzọ (+).
Pharmacology na pharmacokinetics
Mgbe nchịkwa subcutaneous gasịrị, enwere mbelata nke glucose n'ihi mkpali nke iji akụkụ ya na akwara na mkpocha usoro ndị a na imeju. Omume ahụ na-ebido nkeji iri mgbe ịgba ntụtụ ahụ.
Site na ntinye nke Glulisin na insulin mgbe nile nkeji ole na ole tupu nri, onye nke mbụ na-enwe ike nchịkwa kachasị mma mgbe ị risịrị nri. Usoro ndu nke ihe ahu di 70%.
Ikwurita echiche na protein ndị na-emetụta plasma. Ọ ga-adị ntakịrị ngwa ngwa karịa homonụ injection nke mmadụ nkịtị. Nkera ọkara nke 13.5 nkeji.
Ntụziaka maka ojiji
A na-enye ọgwụ ahụ ozugbo tupu nri (maka nkeji 10-15) ma ọ bụ ozugbo nri, na-eburu n'uche usoro ọgwụgwọ n'ozuzu ya na ndị insulins ndị ọzọ (site na oge omume ma ọ bụ site na mbido). Ofzọ nchịkwa: subcutaneously na apata ụkwụ, ubu. Iji zere mmerụ ahụ, a na-agbaji saịtị ịgba ọgwụ mgbochi. A na-enye ọgwụ ahụ n'ọtụtụ ebe, mana n'ime otu mpaghara.
A glulisin tinyere insulins ndị a:
- ya na anaal nke basal;
- na nkezi;
- ogologo;
- na ọgwụ ọgwụ ndị a gbanyere mkpọrọgwụ.
![](http://img.diabetesentity.com/img/diab-2020/8504/ultrakorotkij-insulin-glulizin-harakteristiki-i-osobennosti-primeneniya-2.jpg)
Ike nke glycemia na mgbakwunye nke insulin Glulizin na ọgwụgwọ na insulin basal
Ọ bụrụ na ebumnuche a ga-emezi usoro a site na iji sirinji, a na-eme injeals dị ka ntuziaka maka usoro a si dị. A na-ahọrọ usoro ịsụ ọgwụ ahụ n'otu n'otu, na-eburu n'uche ọnọdụ onye ọrịa na ọkwa nke ụgwọ.
Tupu i jiri Glulizin, jupụta na katriiki, a na-eme nyocha - nsị apịtị na nsonye adịghị mma maka ojiji.
Ntụziaka vidiyo maka iji sirinji sirinji:
Ihe na-egosi, mmetụta dị n'akụkụ, ịdoụbiga mmanya ókè
Edere ọgwụ n’okwu ndị a:
- Ọrịa shuga ;dị 1;
- Ọrịa shuga 2dị 2;
- Ọrịa shuga na ụmụaka si afọ isii.
Ihe ndi choro igbochi ogwu a bu ndi a:
- hypoglycemia;
- hypersensitivity na glulisin;
- hypersensitivity na ihe inyeaka nke ọgwụ.
Mgbe ị na-eji ọgwụ ahụ, ọgwụ ọjọọ nwere ike ime.
Ugboro nke ihe ọghọm na ọnụọgụgụ, ebe 4 bụ ihe zuru oke, 3 na-abụkarị, 2 adịghị obere, 1 dị ụkọ
Nsonaazụ | Oge ngosipụta |
---|---|
hypoglycemia | 4 |
Ngosiputa ihe ojoo nke udiri uzo ozo di iche | 2 |
urticaria, dermatitis | 2 |
nsogbu anaphylactic | 1 |
lipodystrophy | 2 |
mmeghachi omume na-adịghị mma na mpaghara nchịkwa ọgwụ | 3 |
nsogbu metabolic | 2 |
ọrịa mamịrị ketoacidosis | 2 |
ọzịza | 3 |
ọrịa mamịrị retinopathy | 2 |
N'oge ịdoụbiga mmanya ókè, a na-achọpụta hypoglycemia nke ogo ịdị iche iche. Ọ nwere ike ime ọ fọrọ obere ka ọ bụrụ ozugbo.
Dabere na ịdị elu nke ọgwụ insulin, oge na ogo nke ọrịa ahụ, mgbaàmà hypoglycemia nwere ike ịche karịa. Onye ọrịa ahụ kwesịrị ịtụle ozi a iji gbochie ọnọdụ ahụ n'oge oge. Iji mee nke a, ị ga-enwerịrị sugar (swiiti, chọkọleti, cubes dị ọcha) na gị.
Site na hypoglycemia na-agbanwe agbanwe na-agbanwe agbanwe, a na-ewere ngwaahịa ndị nwere shuga. N'ọnọdụ ndị siri ike, nke jikọtara na mmụọ ịma ọkwa, a ga-achọ ọgwụ ntụtụ.
Nkwụsị hypoglycemia na-eme site n'enyemaka nke glucagon (s / c ma ọ bụ m / m), usoro glucose (i / v). N'ime ụbọchị 3, a na-enyocha ọnọdụ onye ọrịa ahụ. Iji gbochie mmepe nke hypoglycemia ugboro ugboro, ọ dị mkpa ị takeụ carbohydrates mgbe oge ụfọdụ.
Mkparịta ụka ọgwụ ọjọọ
Na mmalite ọgwụgwọ na insulin ultrashort, a na-atụle mmekọrịta ya na ọgwụ ndị ọzọ.
Ọtụtụ ọgwụ nwere ike imetụta metabolism glucose, mee ka ọ dịkwuo ma ọ bụ belata mmetụta nke insulin ultrashort. Tupu a gwọọ ya, o kwesịrị ịgwa onye ọrịa ahụ iji gbochie nsonaazụ na-adịghị mma.
Ọgwụ ndị a na-akwalite nsonaazụ Glulisin: Fluoxetine, ndị na-ahụ maka hypoglycemic na mbadamba, ọkachasị, sulfonylureas, sulfonamides, salicylates, fibrates, ACE inhibitors, Disopyramide, MAO inhibitors, Pentoxifylline, Propoxifen.
Ọgwụ ndị na-esote belata mmetụta nke ọgwụ insulin: ọgwụ antipsychotics, ataramu, ọgwụ mgbochi mkpịsị, homonụ thyroid, glucagon, homonụ mmekọahụ nke nwanyị, thiodiphenylamine, somatropin, diuretics, glucocorticosteroid ọgwụ (GCS), protein inhibitors,
A na-atụgharị ọgwụ Pentamidine, beta-mgbochi, na clonidine na ọgwụ ndị a na-atụghị anya ya nwere ike imetụta ike nke mkpịsị Glulisin na ọkwa glucose (ibelata na mmụba). Mmanya nwere otu ihe ala.
A na-ahụkarị ịkpachapụ anya mgbe ọ na-ede akwụkwọ Pioglitazone nye ndị ọrịa nwere ọrịa obi. Mgbe ejikọtara ya, a kọọrọ banyere mmepe nke nkụda obi na ndị ọrịa nwere ịkọwa ọrịa a.
Ọ bụrụ na enweghị ike ịgwọ ọrịa Pioglitazone, ọ dị mkpa iji nyochaa ọnọdụ ahụ. Ọ bụrụ na ekpughere ihe ọ bụla gbasara obi (oke ibu, ọzịza), a ga-akwụsị ị useụ ọgwụ.
Ntụziaka pụrụ iche
Onye ọrịa ahụ kwesịrị ịtụle ihe ndị a:
- Site na mmerụ akụrụ ma ọ bụ mebie ọrụ ha, mkpa insulin nwere ike belata.
- Site na nsị imeju, mkpa ọ na-ebelata.
- N'ihi enweghị data, edeghị ọgwụ maka ụmụaka na-erubeghị afọ isii.
- Jiri nlezianya jiri ụmụ nwanyị dị ime na nleba anya mgbe niile nke ihe ngosi.
- N'oge a na-enye nwa ara, achọrọ ya na idozi nri.
- Mgbe ị na-agbanye na Glulisin site na homonụ ọzọ n’ihi ịba ọcha n’anya, a ga-eme ule nfụkasị iji wepu nfụkasị.
Ndozi usoro onunu ogwu
A na-eme mgbanwe nkwụghachi n'oge mgbanwe site na ụdị ọgwụ mgbochi ọzọ. Mgbe ị na-ebufe site na insulin anụmanụ na Glulisin, a na-agbanwe ọ̀ge ahụ na ntinye nke mbelata nke ikpeazụ. Mkpa ọgwụ ahụ nwere ike gbanwee site na oke mmetụta uche / nsogbu obi, n'oge ọrịa na-efe efe.
A na-achịkwa atụmatụ a site na enyemaka nke ọgwụ ọgwụ hypoglycemic. Ọ bụrụ n’ịgbanwe akụkụ ọ bụla nke atụmatụ ahụ, ịnwere ike ịgbanwe sọọsọ Glulisin.
N'ihe banyere hyperglycemia / hypoglycemia ugboro ugboro, a na-ebu ụzọ akọwapụta ihe ndị a dabere na ọgwụ tupu ị gbanwee usoro ọgwụ a:
- Usoro na ebe nchịkwa ọgwụ;
- rube isi na usoro ọgwụgwọ;
- iji ọgwụ ndị ọzọ eme ihe;
- ọnọdụ uche-mmetụta uche.
Ozi ndi ozo
Ọ dị mma - afọ 2
Ndụ shelf mgbe emepere - ọnwa
Nchekwa - na t si +2 ruo + 8ºC. Emela ifriizi!
Ezumike bụ site na ndenye ọgwụ.
Glulisin bụ otu ihe dị na insulin nke mmadụ:
- Insuman Rapid;
- Humulin;
- Humodar;
- Gensulin P;
- Vosulin P;
- Arụ Ọrụ.
Glulisin bụ homonụ ultrashort maka ịhazi metabolism metabolism. Edere ya na ngwakọta ndị ọzọ, na-eburu n'uche usoro izu nke ahọrọ. Tupu ojiji, ọ dị mkpa ịmụ ntuziaka a kapịrị ọnụ na mmekọrịta ya na ọgwụ ndị ọzọ.